Sigma Healthcare Limited (S5YA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sigma Healthcare Limited (S5YA) has a cash flow conversion efficiency ratio of 0.047x as of January 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€22.39 Million ≈ $26.18 Million USD) by net assets (€477.77 Million ≈ $558.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see S5YA company net worth for the company's overall valuation and market capitalisation.
Sigma Healthcare Limited - Cash Flow Conversion Efficiency Trend (2017–2023)
This chart illustrates how Sigma Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sigma Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sigma Healthcare Limited ranked by their cash flow conversion efficiency. Explore Sigma Healthcare Limited cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kyocera Corporation
F:KYRA
|
0.026x |
|
Huatai Securities Co Ltd
SHG:601688
|
0.170x |
|
Yihai Kerry Arawana Holdings Co Ltd
SHE:300999
|
0.138x |
|
InterGlobe Aviation Limited
NSE:INDIGO
|
1.544x |
|
Lundin Mining Corporation
TO:LUN
|
0.060x |
|
Industrias Peñoles S.A.B. de C.V
MX:PE&OLES
|
0.140x |
|
Bouygues SA
PA:EN
|
0.113x |
|
General Mills Inc
NYSE:GIS
|
0.075x |
Annual Cash Flow Conversion Efficiency for Sigma Healthcare Limited (2017–2023)
The table below shows the annual cash flow conversion efficiency of Sigma Healthcare Limited from 2017 to 2023. View latest Sigma Healthcare Limited stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-01-31 | €477.77 Million ≈ $558.56 Million |
€142.74 Million ≈ $166.88 Million |
0.299x | +415.53% |
| 2022-01-31 | €488.78 Million ≈ $571.43 Million |
€-46.28 Million ≈ $-54.11 Million |
-0.095x | -285.89% |
| 2021-01-31 | €534.90 Million ≈ $625.36 Million |
€-13.12 Million ≈ $-15.34 Million |
-0.025x | -105.77% |
| 2020-01-31 | €476.74 Million ≈ $557.36 Million |
€202.75 Million ≈ $237.04 Million |
0.425x | +2482.27% |
| 2019-01-31 | €514.28 Million ≈ $601.25 Million |
€8.47 Million ≈ $9.90 Million |
0.016x | -88.08% |
| 2018-01-31 | €515.26 Million ≈ $602.39 Million |
€71.18 Million ≈ $83.22 Million |
0.138x | -48.96% |
| 2017-01-31 | €538.59 Million ≈ $629.66 Million |
€145.77 Million ≈ $170.42 Million |
0.271x | -- |
About Sigma Healthcare Limited
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemi… Read more